Page 97 - Haematologica May 2022

Complement dysregulation & COVID-19
doi: 10.1101/2021.01.07.21249116
[preprint, not peer-reviewed].
35. Pekayvaz K, Leunig A, Kaiser R, et al.
Protective immune trajectories in early viral containment of non-pneumonic SARS- CoV-2 infection. bioRxiv. doi: https://doi.org/10.1101/2021.02.03.429351 [preprint, not peer-reviewed].
36.Ma L, Sahu SK, Cano M, et al. Increased complement activation is a distinctive fea- ture of severe SARS-CoV-2 infection. Sci Immunol. 2021;6(59):1-18.
37. Mastellos DC, Pires da Silva BGP, Fonseca BAL, et al. Complement C3 vs C5 inhibi- tion in severe COVID-19: early clinical findings reveal differential biological effica- cy. Clin Immunol. 2020;220:108598.
38.Rambaldi A, Gritti G, Micò MC, et al. Endothelial injury and thrombotic microan-
giopathy in COVID-19: treatment with the lectin-pathway inhibitor narsoplimab. Immunobiology. 2020;225(6):152001.
39. Perkins SJ, Fung KW, Khan S. Molecular interactions between complement factor H and its heparin and heparan sulfate ligands. Front Immunol. 2014;5:1-14.
40. Polack FP, Thomas SJ, Kitchin N, et al. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. N Engl J Med. 2020;383(27):2603-2615.
41. Baden LR, El Sahly HM, Essink B, et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 Vaccine. N Engl J Med. 2021;384(5):403-416.
42. Gavriilaki E, Brodsky RA. Complementopathies and precision medi- cine. J Clin Invest. 2020;130(5):2152-2163.
43. Ville S, Le Bot S, Chapelet-Debout A, et al.
Atypical HUS relapse triggered by COVID-
19. Kidney Int. 2021;99(1):267-268.
44. Gerber GF, Yuan X, Yu J, et al. COVID-19 Vaccines induce severe hemolysis in parox- ysmal nocturnal hemoglobinuria. Blood.
2021;137(26):3670-3673.
45. Shim K, Begum R, Yang C, Wang H.
Complement activation in obesity, insulin resistance, and type 2 diabetes mellitus. World J Diabetes. 2020;11(1):1-12.
46.Kulkarni S, Fisk M, Kostapanos M, et al. Repurposed immunomodulatory drugs for Covid-19 in pre-ICU patients - multi-arm Therapeutic study in pre-ICU patients admitted with Covid-19 - repurposed drugs (TACTIC-R): a structured summary of a study protocol for a randomised controlled trial. Trials. 2020;21 (1):20-22.
haematologica | 2022; 107(5)
1105